Dr. Bhanu Prakash Bandlamudi
Rating
4.8/5
Total Surgeries
1000+
Category
Premium Multi-Speciality
Specialization : Bone Marrow Transplantation , Hematology , Oncology , Surgical Oncology
Position held
Consultant Medical & Hemato Oncologist, Yashoda Hospitals, Secunderabad
Consultant Medical Oncology and Haemato Oncology, Medicover Cancer Institute
Senior Residency, Medical Oncology and Bone Marrow Transplant, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry
Senior Residency, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGI), Lucknow
Residency in the Department of Radiation Oncology, Manipal University of Health Sciences, Manipal
1000+
Expert Complex
Procedures Performed
Specialization
Breast Cancer
Lung Cancer
Genitourinary Cancers
Gastrointestinal Cancers
Gynaecological Cancers
Paediatric Cancers
Haematological Malignancies and Stem Cell Transplantation
Preventive Oncology and Hereditary Cancers-Screening and Genetic Counselling
Palliative and Supportive Care for Advanced Cancer
Targeted Therapy (Precision Oncology)
Key Treatments
- Treatment for Hematolymphoid Cancers and Stem Cell Transplantation
- Paediatric Oncology
- Cancer Screening with Genetic Counselling
- Palliative and Supportive Care for Advanced Cancer Patients
- Targeted Therapy (Precision Oncology)
- Chemotherapy for Solid Tumours (Breast Cancer, Lung Cancer, Stomach Cancer, Colon Cancer
- Breast Cancer Management
- Genitourinary Malignancies
- Intensity Modulated Radio Therapy (IMRT)
- Stereotactic Body Radio Therapy (SBRT)
Affiliations
Member of American Society of Clinical Oncology (ASCO)
European Society for Radiotherapy & Oncology (ESTRO)
American Society for Radiation Oncology (ASTRO)
European Society of Medical Oncology (ESMO)
Indian Society of Medical and Paediatric Oncology (ISMPO)
Professional Summary
Dr. Bhanu Prakash Bandlamudi is one of the best Consultant Medical & Haemato-Oncologists in Hyderabad. He has a keen interest and expertise in the management of Breast Cancer, Lung Cancer, Gastrointestinal Cancers, Urogenital Cancers, Blood Cancer and Bone Marrow Transplants. He always keeps himself updated with the latest advancements in the field of oncology and is committed to presenting all available options to the patient and guiding them through the process diligently.
Publications
Yathiraj, P.H., Prakash, B., Sharan, K., Singh, A., Reddy, S.A., Chandraguthy, S.G., Balasubramanian, R.,Nagesh, J., Nair, S.S., Fernandes, D. and Vidyasagar, M.S., 2016. Dosimetric analysis and clinical outcomes of brachial plexus as an organ-at-risk in head and neck cancer patients treated with intensity modulated radiation therapy. International Journal of Radiation Oncology• Biology• Physics, 96(2), pp. E379-E380
Prakash BB, Yathiraj PH, Sharan TK, Singh A, Reddy AS, Chandraguthi SG, Subramanian RB, Nagesh J, Nair SS, Fernandes DJ, Mamidipudi VS. Dosimetric analysis and clinical outcomes of brachial plexus as an organ-at-risk in head-and-neck cancer patients treated with intensity-modulated radiotherapy
Kumar R, Razab S, Prabhu K, Ray S, Prakash B. Serum butyrylcholinesterase and zinc in breast cancer. Journal of Cancer Research and Therapeutics. 2017 Apr 1;13(2):367
Ponraj M, Dubashi B, Harish BH, Kayal S, Cyriac SL, Pattnaik J, Ranjith K, PillaiUS, Jadhav N, Prakash.B. Cefepime vs. cefoperazone/sulbactam in combination with amikacin as empirical antibiotic therapy in febrile neutropenia. Supportive Care in Cancer. 2018 Nov 1;26(11):3899-908
Gopal V, Kayal S, Dubashi B, Menon V, Veeraiah S, Sivakumar C, Jayalakshmi R, Bandlamudi BP, Bhattacharjee A, Dahagama S, Kalpana D. Psychosocial counselling of patients planned for hematopoietic stem-cell transplantation for malignant conditions—practical challenges and solutions from India. Indian Journal of Cancer. 2021 Jan 1;58(1):122